Develops drugs for cystic fibrosis, sickle cell disease, and kidney diseases.
Jun 2026Revenue $12.6B/yrExpenses $7.81B/yr
No trend
Figures by year
Is Vertex Pharmaceuticals profitable?
Yes. In the 12 months to Jun 2026, revenue was $12.6B and expenses $7.81B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $12.0B | $7.83B | $4.17B |
| Dec 2024 | $11.0B | $11.3B | −$233M |
| Dec 2023 | $9.87B | $6.04B | $3.83B |
| Dec 2022 | $8.93B | $4.62B | $4.31B |
| Dec 2021 | $7.57B | $4.79B | $2.78B |
| Dec 2020 | $6.21B | $3.35B | $2.86B |
| Dec 2019 | $4.16B | $2.97B | $1.20B |
| Dec 2018 | $3.05B | $2.41B | $635M |
| Dec 2017 | $2.49B | $2.37B | $123M |
| Dec 2016 | $1.70B | $1.69B | $9.94M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.